Navigation Links
Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo

eth and Solvay Pharmaceuticals as well as co-developed and co-commercialized by the two companies.

About Schizophrenia

Schizophrenia is a chronic form of psychosis that affects approximately 1.1 percent of the population in the United States in one year. It is characterized by positive and negative symptoms such as hallucinations, delusions, poverty of speech, disorganized thought and emotional blunting. Severity of the symptoms and the long-term pattern of schizophrenia often cause a high degree of disability for patients and place a burden on families, caregivers and communities.

While atypical antipsychotics help reduce positive and negative symptoms to varying degrees, some may be associated with weight gain, glucose and triglyceride elevations, and altered lipids, which may increase the risk of diabetes and heart disease. These side effects are compounded by the fact that individuals with schizophrenia are more likely than the general population to be overweight or obese, and they have a higher risk of diabetes than the general population.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Managing Preanalytical Processes for Patient Safety
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
7. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
10. Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR
11. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care

Post Your Comments:
(Date:11/6/2009)...Mass., Nov. 6 Facet Solutions, Inc...assets of Archus Orthopedics. The acquisition crea...fferings, intellectual property and clinical exper... win for patients suffering from lumbar spinal ste...O, Geoff Pardo. "This consolidation further stren...
(Date:11/6/2009)...anitoba, Nov. 6 With his proposed ...s set his sights on cutting name-brand prescriptio...ho fall into the "Part D" coverage gap, universall...bout the potential cost-cutting and feel it,s a pr...he most powerful lobbyists want a revised program ...
(Date:11/6/2009)...v. 6 GeoVax Labs, Inc. ...any"), an Atlanta-based, biopharmaceutical company...HIV-1 (Human Immunodeficiency Virus) and other inf...2009 financial results and provided an operational...d Chief Executive Officer commented, "We are pleas...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8ReBuilder Medical Technologies Inc Announces First Quarter 2009 is Profitable 55336 1ReBuilder Medical Technologies Inc Announces First Quarter 2009 is Profitable 55336 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 1Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 3Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 4Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 5Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 6Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 7Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 8HPV Vaccine Could Prevent Many Penile Cancers 55330 1HPV Vaccine Could Prevent Many Penile Cancers 55330 2
...(TM) HBSAG Test Found to Have Higher Sensitivity a...FirstVue(TM) ,...and was the preferred ... SPRINGS, Fla., Oct. 13 AT First Diagnostic LLC a...gnostic test kits, today,announced that a recent e...ute of Research of the FirstVue(TM) HBSAG Test, wa...
...n of Genomic DNA from Multiple Cancer Populations ...dies, ANN ARBOR, Mich., Oct. 13 Rubicon Genomics...erick to amplify DNA samples for The,Cancer Atlas ... amplify and standardize total genomic,DNA from 3,... The Rubicon,GenomePlex(TM) Whole Genome Amplifica...
Other Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3
(Date:11/9/2009)... Leading U.S. air ambulance company no...EURAMI accreditation and Department of Defense app...PRWEB) November 9, 2009 -- AirMed International, t...oday it has earned full accreditation from the Eur...a Stuttgart, Germany, based non-profit association...
(Date:11/9/2009)...K, Nov. 9 Davis Bregman , a pai...e calls to residents of Manhattan in New York City... by calling the office at 212-918-1629 or sendin...ence of being able to see the doctor in the less s... this new way of seeing most patients. The servic...
(Date:11/8/2009)...TON, Nov. 8 Jon O,Brien...llowing statement about the passage of HR 3962: ,...erican voters a lot about core values. We in the p... seeking to overcome the struggles ordinary Americ...at many cannot afford basic healthcare or have to ...
(Date:11/8/2009)... UCW Academy of Health holds open hous...ctoria, BC (Vocus) November 8, 2009 -- UCW Academy...r in British Columbia’s health care industry...ay, November 25, 2009. , ,UCW Academy of Health, ...ion, nursing and social services, designs its prog...
(Date:11/8/2009)... New book called "Preventing and ...r. Roberto Giraldo shows that AIDS is a result of ...ty of so-called immune system stressor agents, whi...nd most of all, emotional. , ...Nov. 6 – 8, 2009, cell biologists, physician...
Breaking Medicine News(10 mins):Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
... The more overweight children are, the poorer qual...ing to a new study.// Nearly 2,000 children par...th-related quality of life using a short survey co...he children studied were not overweight; about 20 ...
... A new study shows a clear link between fast food ..., suggesting that // fast food increases the risk ...estigated the association between reported fast fo... that changes in fast food frequency over 15 years...
... A new study shows men who consume three or more a...stroke. An ischemic stroke develops // when an art... Researchers studied more than 38,000 participan...mic stroke among the study participants. Results o...
... Moderate physical exercise can significantly redu... heart disease in older adults //, say researchers...revious cardiovascular disease, between ages 55 an...ics. The other half only received a booklet encour...
... The wet form of macular degeneration represents a... Age-related macular degeneration is the leading c... 50 years of age and older. // Two new studies sho...centers in the United States, Canada, Europe, Isra...
... High blood sugar, or hyperglycemia, is a common p...f whether they are diabetic or not.// The conditio...insulin resistance, impaired glucose metabolism, v...nvestigated more than 1,800 consecutive patients a...
Other Medicine News:
Pefakit TDT
Pefakit PiCT Controls LMWH
Pefakit TAFI Calibrator/Control
QuikCoag Control 3
Medicine Products: